Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Core Laboratories's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 81.12.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Core Laboratories's liquidation value for the
three
months ended in Mar. 2026 was MXN-3,240 Mil.
Core Laboratories (MEX:CLB) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Core Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories Change In Receivables Related Terms
Core Laboratories Change In Receivables Historical Data
* Premium members only.
The historical data trend for Core Laboratories's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories Change In Receivables Calculation
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN124 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of MXN124 Mil mean?
Core Laboratories (MEX:CLB) has a Change In Receivables of MXN124 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Core Laboratories and its competitors.
Is Core Laboratories' Change In Receivables too high?
Core Laboratories' current Change In Receivables is MXN124 Mil. Overall, Core Laboratories has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Change In Receivables compare to EROK and OIS?
Core Laboratories' Change In Receivables of MXN124 Mil can be compared against companies in the Oil & Gas industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for an Oil & Gas company?
A good Change In Receivables depends on the Oil & Gas industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Core Laboratories and its competitors. Core Laboratories's current Change In Receivables is MXN124 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Core Laboratories (MEX:CLB) has a current Change In Receivables of MXN124 Mil. The stock's GF Value™ is MXN1,314.29, compared to a current price of MXN856.38 — trading 34.8% below its estimated fair value. The current Change In Receivables is MXN124 Mil. Core Laboratories' overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Core Laboratories (MEX:CLB), the current Change In Receivables is MXN124 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (MEX:CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of MXN856.38 is trading 34.8% below its estimated GF Value™ of MXN1,314.29.
Key valuation signals for MEX:CLB:
Change In Receivables: MXN124 Mil
GF Value™: MXN1,314.29 vs. price of MXN856.38 (34.8% below fair value)
No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
59GF Score
Get the complete analysis for MEX:CLB
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CLB has been successfully added to your 
